Wegener's granulomatosis: evolving concepts in treatment.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Seminars in Respiratory and Critical Care Medicine

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2004-836143PMID 16088495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

  2010cited by this paper
• Therapy-related leukaemia in Wegener's granulomatosis.

  2008cited by this paper
• Wegener ’ s Granulomatosis Presenting as a Primary Seizure Disorder with Brain Lesions Demonstrated by Magnetic Resonance Imaging

  2006cited by this paper
• Head and neck manifestations of Wegener's granulomatosis.

  2006cited by this paper
• Wegener's granulomatosis of the prostate gland

  2004cited by this paper
• Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis.

  2004cited by this paper
• Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions

  2004cited by this paper
• Churg-Strauss Syndrome

  2004cited by this paper
• Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.

  2003cited by this paper
• A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

  2003cited by this paper
• Treatment of subglottic stenosis, due to Wegener's granulomatosis, with intralesional corticosteroids and dilation.

  2003cited by this paper
• Clinical value of gallium-67 scintigraphy in assessment of disease activity in Wegener’s granulomatosis

  2003cited by this paper
• Bilateral parotid and submandibular gland enlargement: rare features of Wegener’s granulomatosis

  2003cited by this paper
• Cardiac Wegener's granulomatosis masquerading as left atrial myxoma.

  2003cited by this paper
• Wegener's granulomatosis with cardiac involvement masquerading as Lyme disease.

  2003cited by this paper
• Cutaneous Wegener's granulomatosis (malignant pyoderma) in a patient with Crohn's disease

  2003cited by this paper
• Wegener's granulomatosis presenting as pyoderma gangrenosum

  2003cited by this paper
• Medium- and large-vessel vasculitis.

  2003cited by this paper
• Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.

  2003cited by this paper
• Computed Tomography Features of the Thoracic Manifestations of Wegener Granulomatosis

  2003cited by this paper
• Pseudotumour orbitae as the initial manifestation in Wegener’s granulomatosis in a 7-year-old girl

  2003cited by this paper
• Head and neck manifestations of Wegener's granulomatosis.

  2003cited by this paper
• MR Imaging in Wegener granulomatosis of the spinal cord.

  2003influential reference
• Wegener granuloma in the fourth ventricle.

  2003cited by this paper
• Wegener's granulomatosis: current and upcoming therapies

  2003cited by this paper
• Subglottic Stenosis Associated With Wegener's Granulomatosis

  2003influential reference
• Wegener's granulomatosis: an analysis of 33 patients seen over a 10-year period.

  2003cited by this paper
• Churg-Strauss syndrome.

  2003cited by this paper
• 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.

  2003cited by this paper
• Wegener's granulomatosis presenting with otologic and neurologic symptoms: clinical and pathological correlations.

  2003cited by this paper
• Long‐Term Follow‐up of Repair of External Nasal Deformities in Patients With Wegener's Granulomatosis

  2002cited by this paper
• Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.

  2002cited by this paper
• Frequency and patterns of subclinical cognitive impairment in patients with ANCA-associated small vessel vasculitides.

  2002cited by this paper
• Clinical features in 17 paediatric patients with Wegener granulomatosis

  2002cited by this paper
• Optic neuritis as a feature of Wegener’s granulomatosis

  2002cited by this paper
• Incomplete septal cirrhosis associated with Wegener's granulomatosis.

  2002cited by this paper
• Role of thoracic surgery and interventional bronchoscopy in Wegener's granulomatosis.

  2002cited by this paper
• MR imaging findings of spinal dural involvement with Wegener granulomatosis.

  2002cited by this paper
• Cancer incidence in a population‐based cohort of patients with Wegener's granulomatosis

  2002cited by this paper
• Otologic Manifestations of Wegener's Granulomatosis

  2002cited by this paper
• Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients

  2002cited by this paper
• F-18 FDG–Positron Emission Tomographic Scanning and Wegener’s Granulomatosis

  2002cited by this paper
• Control of a relapse and induction of long-term remission of Wegener's granulomatosis by cyclosporine.

  2002cited by this paper
• Complete Heart Block in a Patient with Wegener's Granulomatosis in Remission

  2002cited by this paper
• Rhinologic changes in Wegener’s granulomatosis

  2002cited by this paper
• Peripheral Blood and Granuloma CD4+CD28− T Cells Are a Major Source of Interferon-γ and Tumor Necrosis Factor-α in Wegener’s Granulomatosis

  2002cited by this paper
• Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.

  2002cited by this paper
• Vasculitis in childhood.

  2002cited by this paper
• Benign Tracheobronchial Stenoses: Changes in Short-Term and Long-Term Pulmonary Function Testing After Expandable Metallic Stent Placement

  2002cited by this paper
• Imaging evidence of successful multiple immunosuppressive treatment of cerebral involvement in Wegener's granulomatosis.

  2002cited by this paper
• Active disease and residual damage in treated Wegener's granulomatosis: an observational study using pulmonary high-resolution computed tomography

  2002cited by this paper
• CT virtual bronchoscopy of the central airways in patients with Wegener's granulomatosis.

  2002cited by this paper
• Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up.

  2001cited by this paper
• A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

  2001cited by this paper
• Acute upper gastrointestinal haemorrhage and colitis: an unusual presentation of Wegener's granulomatosis.

  2001cited by this paper
• Orbital involvement as the first manifestation in classic Wegener's granulomatosis

  2001cited by this paper
• Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective.

  2001influential reference
• Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis

  2001cited by this paper
• Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis.

  2001influential reference
• Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.

  2001cited by this paper
• Bony Abnormalities of the Paranasal Sinuses in Patients with Wegener's Granulomatosis

  2001cited by this paper
• Wegener’s granulomatosis presenting with bilateral facial nerve palsy

  2001cited by this paper
• Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.

  2001cited by this paper
• Multiple renal masses as initial manifestation of Wegener's granulomatosis.

  2001cited by this paper
• Australasian orbital and adnexal Wegener's granulomatosis.

  2001influential reference
• Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis

  2001cited by this paper
• Circulating soluble adhesion molecules in ANCA-associated vasculitis.

  2001cited by this paper
• Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study.

  2001influential reference
• Facial paralysis in Wegener’s granulomatosis of the middle ear

  2001cited by this paper
• Standardized neurologic evaluations of 128 patients with Wegener granulomatosis.

  2001influential reference
• Vasculitis of the internal carotid artery in Wegener's granulomatosis: comparison of ultrasonography, angiography, and MRI.

  2001cited by this paper
• Expression of the chemokine RANTES in pulmonary Wegener's granulomatosis.

  2001influential reference
• Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.

  2001cited by this paper
• Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener's granulomatosis.

  2001cited by this paper
• Wegener's granulomatosis: the relationship between ocular and systemic disease.

  2001cited by this paper
• CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis

  2001cited by this paper
• A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis.

  2001cited by this paper
• Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.

  2001cited by this paper
• Cerebral and Oculorhinal Manifestations of a Limited Form of Wegener's Granulomatosis With c‐ANCA—Associated Vasculitis

  2001cited by this paper
• The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review.

  2001cited by this paper
• TREATEMENT OF WEGENER'S GRANULOMATOSIS

  2001cited by this paper
• Opsonization of apoptotic neutrophils by anti‐neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor‐alpha (TNF‐α)

  2000cited by this paper
• Wegener's granulomatosis: clinical course in 108 patients with renal involvement.

  2000cited by this paper
• Percutaneous image-guided biopsy of lung nodules in the assessment of disease activity in Wegener's granulomatosis.

  2000cited by this paper
• Splenic infarction in Wegener's granulomatosis.

  2000cited by this paper
• Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expression.

  2000influential reference
• Pathogenesis of ANCA‐associated systemic vasculitis

  2000influential reference
• Wegener's granulomatosis presenting as a renal mass.

  2000cited by this paper
• Wegener granulomatosis in children and young adults. A case study of ten patients.

  2000cited by this paper
• Longterm outcome of Wegener's granulomatosis in patients with renal disease requiring dialysis.

  2000influential reference
• Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.

  2000cited by this paper
• Churg-Strauss syndrome

  2000cited by this paper
• Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy.

  2000cited by this paper
• Periaortitis and Aortic Dissection due to Wegener’s Granulomatosis

  2000cited by this paper
• Cardiac involvement in patients with Wegener's granulomatosis

  2000cited by this paper
• The clinical value of septal perforation biopsy.

  2000cited by this paper
• Localised Wegener’s Granulomatosis in Otolaryngology: A Review of Six Cases

  2000cited by this paper
• Campath-1H therapy in refractory ocular inflammatory disease

  2000cited by this paper
• Small vessel vasculitis of the lung

  2000cited by this paper
• Epidemiology of Wegener's granulomatosis in northern Norway.

  2000cited by this paper

• Antineutrophil cytoplasmic antibody-associated vasculitides: Clinical manifestations and pulmonary involvement

  2024influential citation
• Case of Strawberry Gum Associated With Polyangiitis Granulomatosa in Relation to Cytoplasmic Antineutrophil Cytoplasmic Antibody

  2023cites this paper
• Predictors of relapse in granulomatosis with polyangiitis: a multi-center study

  2022cites this paper
• Vascular Disorders of the Lung

  2020cites this paper
• Revisión Afectación pulmonar de las vasculitis

  2019cites this paper
• Case report of a patient with cANCA vasculitis without airway involvement

  2019cites this paper
• An uncommon presentation of Granulomatosis with Polyangiitis

  2018cites this paper
• Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment

  2018cites this paper
• AN EDITION OF GREEK RHEUMATOLOGY SOCIETY AND PROFESSIONAL ASSOCIATION OF RHEUMATOLOGISTS

  2017cites this paper
• Hemorragia alveolar difusa: frecuencia, causa y desenlace

  2016cites this paper
• Refractory otitis media as the first manifestation of Wegener's granulomatosis

  2015cites this paper
• Sulfonamides and Trimethoprim

  2015cites this paper
• Inflammatory pseudotumor of the urinary bladder presenting as a symptom of active vasculitis in a patient with granulomatosis with polyangiitis (Wegener's) - an unusual manifestation of ANCA-associated vasculitis

  2014cites this paper
• Anti-neutrophil cytoplasmic antibody-associated vasculitis associated with infectious mononucleosis due to primary Epstein–Barr virus infection: report of three cases

  2013cites this paper
• [Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: advances in pathogenesis and treatment].

  2013cites this paper
• Pulmonary affectation of vasculitis.

  2012cites this paper
• Pulmonary Affectation of Vasculitis

  2012cites this paper
• Pharmacological Therapy for Wegener’s Granulomatosis

  2012cites this paper
• Wegener Granulomatosis (Granulomatosis with Polyangiitis): Evolving Concepts in Treatment

  2011influential citation
• Immunosuppressive and Cytotoxic Therapy: Pharmacology, Toxicities, and Monitoring

  2011influential citation
• Immunosuppressives (chlorambucil, cyclosporine, cyclophosphamide [Cytoxan], azathioprine [Imuran], mofetil, tacrolimus)

  2011cites this paper
• 66 – Afectación pleuropulmonar en las enfermedades nefrourológicas

  2010cites this paper
• Refractory otitis media as the first manifestation of Wegener's granulomatosis.

  2010cites this paper
• Granulomatosis de Wegener tipo limitante (vasculítica). Hallazgo en la autopsia de un niño

  2009cites this paper
• An adolescent with both Wegener's Granulomatosis and chronic blastomycosis

  2008cites this paper
• B-Cell Depletion in Wegener’s Granulomatosis

  2008cites this paper
• Azathioprin bei Vaskulitiden

  2008cites this paper
• Diagnostic Approach to Diffuse Parenchymal Lung Disease

  2007cites this paper
• Oral manifestations of Wegener's granulomatosis: a report of three cases and a literature review.

  2007cites this paper
• [Progressive hearing loss as the leading sign of Wegener's granulomatosis].

  2007cites this paper
• Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review.

  2007cites this paper
• Manifestaciones pulmonares de las enfermedades sistémicas

  2006cites this paper
• Fever and Penis Ulcer in an 87-Year-Old Man

  2006cites this paper
• Diagnosis and Management of Wegener's Granulomatosis in a Dog

  2006influential citation
• Mechanisms of endothelial cell dysfunction in Wegener´s granulomatosis

  2005cites this paper
• Management of Wegener Granulomatosis

  2005cites this paper